Reuters logo
BRIEF-PAION announces clinical development progress with remimazolam
November 23, 2017 / 1:06 PM / 21 days ago

BRIEF-PAION announces clinical development progress with remimazolam

Nov 23 (Reuters) - PAION AG:

* DGAP-NEWS: PAION ANNOUNCES CLINICAL DEVELOPMENT PROGRESS WITH REMIMAZOLAM BY ITS PARTNER HANA PHARM IN SOUTH KOREA

* ‍HANA PHARM PLANS TO SUBMIT A MARKETING AUTHORIZATION APPLICATION IN 2018​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below